Literature DB >> 26269172

Nef Is Dispensable for Resistance of Simian Immunodeficiency Virus-Infected Macrophages to CD8+ T Cell Killing.

Jennifer N Rainho1, Mauricio A Martins2, Francesc Cunyat1, Ian T Watkins1, David I Watkins2, Mario Stevenson3.   

Abstract

UNLABELLED: Simian immunodeficiency virus (SIV)-specific CD8(+) T cells kill SIV-infected CD4(+) T cells in an major histocompatibility complex class I (MHC-I)-dependent manner. However, they are reportedly less efficient at killing SIV-infected macrophages. Since the viral accessory protein Nef has been shown to downregulate MHC-I molecules and enhance cytotoxic T lymphocyte (CTL) evasion in human immunodeficiency virus type 1 (HIV-1)-infected CD4(+) T cells, we examined whether Nef played a role in protecting SIV-infected macrophages from killing by SIV-specific CD8(+) T cells. To explore the role of Nef in CD8(+) T cell evasion, we compared the ability of freshly sorted SIV-specific CD8(+) T cells to readily suppress viral replication or eliminate CD4(+) T cells or monocyte-derived macrophages infected with SIV variants containing wild-type (WT) or mutated nef genes. As expected, SIV-specific CD8(+) T cells suppressed viral replication and eliminated the majority of SIV-infected CD4(+) T cells, and this killing was enhanced in CD4(+) T cells infected with the nef variants. However, macrophages infected with nef variants that disrupt MHC-I downregulation did not promote rapid killing by freshly isolated CD8(+) T cells. These results suggest that mechanisms other than Nef-mediated MHC-I downregulation govern the resistance of SIV-infected macrophages to CD8(+) T cell-mediated killing. This study has implications for viral persistence and suggests that macrophages may afford primate lentiviruses some degree of protection from immune surveillance. IMPORTANCE: Myeloid cells are permissive for HIV/SIV replication in vitro and may contribute to viral persistence in vivo. While many studies have been geared to understanding how CD8(+) T cells control viral replication in CD4(+) T cells, the role of these cells in controlling viral replication in macrophages is less clear. Primary, unstimulated CD8(+) T cells insignificantly suppress viral replication or eliminate SIV-infected macrophages. Since the viral Nef protein downregulates MHC-I and provides infected cells some degree of protection from CD8(+) T cell-mediated effector functions, we evaluated whether Nef may be contributing to the resistance of macrophages to CD8(+) T cell suppression. Our results suggest that Nef is not involved in protecting infected macrophages from CD8(+) T cell killing and suggest that other mechanisms are involved in macrophage evasion from CD8 surveillance.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26269172      PMCID: PMC4580207          DOI: 10.1128/JVI.01699-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?

Authors:  Thorsten U Vogel; Thomas C Friedrich; David H O'Connor; William Rehrauer; Elizabeth J Dodds; Heather Hickman; William Hildebrand; John Sidney; Alessandro Sette; Austin Hughes; Helen Horton; Kathy Vielhuber; Richard Rudersdorf; Ivna P De Souza; Matthew R Reynolds; Todd M Allen; Nancy Wilson; David I Watkins
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Macrophages archive HIV-1 virions for dissemination in trans.

Authors:  Natalia Sharova; Catherine Swingler; Mark Sharkey; Mario Stevenson
Journal:  EMBO J       Date:  2005-05-26       Impact factor: 11.598

4.  Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines.

Authors:  Takehiro Matsuda; Alex Almasan; Mariko Tomita; Jun-nosuke Uchihara; Masato Masuda; Kazuiku Ohshiro; Nobuyuki Takasu; Hideo Yagita; Takao Ohta; Naoki Mori
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

Authors:  K L Collins; B K Chen; S A Kalams; B D Walker; D Baltimore
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

6.  Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4(+) T cells.

Authors:  P Secchiero; P Mirandola; D Zella; C Celeghini; A Gonelli; M Vitale; S Capitani; G Zauli
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

Review 7.  Emerging strategies to deplete the HIV reservoir.

Authors:  Nancie M Archin; David M Margolis
Journal:  Curr Opin Infect Dis       Date:  2014-02       Impact factor: 4.915

8.  Epstein-Barr virus BHRF1 functions downstream of Bid cleavage and upstream of mitochondrial dysfunction to inhibit TRAIL-induced apoptosis in BJAB cells.

Authors:  Michiko Kawanishi; Saeko Tada-Oikawa; Shosuke Kawanishi
Journal:  Biochem Biophys Res Commun       Date:  2002-09-27       Impact factor: 3.575

Review 9.  HIV-1 Nef: at the crossroads.

Authors:  John L Foster; J Victor Garcia
Journal:  Retrovirology       Date:  2008-09-22       Impact factor: 4.602

10.  Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein.

Authors:  Simon Swingler; Angela M Mann; Jin Zhou; Catherine Swingler; Mario Stevenson
Journal:  PLoS Pathog       Date:  2007-09-07       Impact factor: 6.823

View more
  18 in total

1.  Short Communication: HIV Controller T Cells Effectively Inhibit Viral Replication in Alveolar Macrophages.

Authors:  Victoria E Walker-Sperling; Christian A Merlo; Robert W Buckheit; Allison Lambert; Patrick Tarwater; Greg D Kirk; M Bradley Drummond; Joel N Blankson
Journal:  AIDS Res Hum Retroviruses       Date:  2016-08-02       Impact factor: 2.205

Review 2.  Impact of Myeloid Reservoirs in HIV Cure Trials.

Authors:  Brooks I Mitchell; Elizabeth I Laws; Lishomwa C Ndhlovu
Journal:  Curr HIV/AIDS Rep       Date:  2019-04       Impact factor: 5.071

3.  Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection.

Authors:  Dionna W Williams; Elizabeth L Engle; Erin N Shirk; Suzanne E Queen; Lucio Gama; Joseph L Mankowski; M Christine Zink; Janice E Clements
Journal:  Am J Pathol       Date:  2016-06-18       Impact factor: 4.307

4.  Colony-Stimulating Factor 1 Receptor Antagonists Sensitize Human Immunodeficiency Virus Type 1-Infected Macrophages to TRAIL-Mediated Killing.

Authors:  Francesc Cunyat; Jennifer N Rainho; Brian West; Louise Swainson; Joseph M McCune; Mario Stevenson
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

Review 5.  Strategies to target non-T-cell HIV reservoirs.

Authors:  Jonah B Sacha; Lishomwa C Ndhlovu
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

Review 6.  SIV Latency in Macrophages in the CNS.

Authors:  Lucio Gama; Celina Abreu; Erin N Shirk; Suzanne E Queen; Sarah E Beck; Kelly A Metcalf Pate; Brandon T Bullock; M Christine Zink; Joseph L Mankowski; Janice E Clements
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

7.  Brain macrophages harbor latent, infectious simian immunodeficiency virus.

Authors:  Celina Abreu; Erin N Shirk; Suzanne E Queen; Sarah E Beck; Lisa M Mangus; Kelly A M Pate; Joseph L Mankowski; Lucio Gama; Janice E Clements
Journal:  AIDS       Date:  2019-12-01       Impact factor: 4.177

Review 8.  Host and Viral Factors Influencing Interplay between the Macrophage and HIV-1.

Authors:  Viviane Machado Andrade; Mario Stevenson
Journal:  J Neuroimmune Pharmacol       Date:  2018-07-11       Impact factor: 4.147

9.  HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responses.

Authors:  Kiera L Clayton; Geetha Mylvaganam; Alonso Villasmil-Ocando; Heather Stuart; Marcela V Maus; Mohammad Rashidian; Hidde L Ploegh; Bruce D Walker
Journal:  Cell Host Microbe       Date:  2021-02-10       Impact factor: 21.023

Review 10.  Targeting the Latent Reservoir for HIV-1.

Authors:  Srona Sengupta; Robert F Siliciano
Journal:  Immunity       Date:  2018-05-15       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.